Search Results - "Chutaputti, A."

What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? by Fan, Jian-Gao, Saibara, Toshiji, Chitturi, Shivakumar, Kim, Byong Ik, Sung, Joseph J Y, Chutaputti, A

“…The risk factors and settings for non‐alcoholic fatty liver disease (NAFLD) in Asians are reviewed comprehensively. Based particularly on large community‐based…”
Get full text

Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naïve patients with HBV-related decompensated cirrhosis by Chan, H. L.Y., Chen, Y. C., Gane, E. J., Sarin, S. K., Suh, D. J., Piratvisuth, T., Prabhakar, B., Hwang, S. G., Choudhuri, G., Safadi, R., Tanwandee, T., Chutaputti, A., Yurdaydin, C., Bao, W., Avila, C., Trylesinski, A.

“…Patients with decompensated cirrhosis owing to chronic hepatitis B viral (HBV) infection have a high morbidity/mortality rate, and the treatment remains a…”
Get full text

Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection by McCaughan, G W, Omata, M, Amarapurkar, D, Bowden, S, Chow, W C, Chutaputti, A, Dore, G, Gane, E, Guan, R, Hamid, S S, Hardikar, W, Hui, C K, Jafri, W, Jia, J-D, Lai, M-Y, Wei, L, Leung, N, Piratvisuth, T, Sarin, S, Sollano, J, Tateishi, R

Get full text

Chronic hepatitis B virus infection in Asian countries by Merican, I, Guan, R, Amarapuka, D, Alexander, Mj, Chutaputti, A, Chien, Rn, Hasnian, Ss, Leung, N, Lesmana, L, Phiet, Ph, Sjalfoellah Noer, Hm, Sollano, J, Sun, Hs, Xu, Dz

“…Of the estimated 50 million new cases of hepatitis B virus (HBV) infection diagnosed annually, 5–10% of adults and up to 90% of infants will become chronically…”
Get full text

Spontaneous bacterial peritonitis [SBP] by Chutaputti, A

Get full text

7 TREATMENT OF DECOMPENSATED HBV-CIRRHOSIS: RESULTS FROM 2-YEARS RANDOMIZED TRIAL WITH TELBIVUDINE OR LAMIVUDINE by Gane, E.J, Chan, H.L, Choudhuri, G, Suh, D.J, Chutaputti, A, Safadi, R, Tanwandee, T, Thongsawat, S, Assy, N, Sarin, S.K, Bao, W, Trylesinski, A, Avila, C

Get full text

706 SUSTAINED DURABILITY OF HBEAG SEROCONVERSION IN CHRONIC HEPATITIS B PATIENTS AFTER TREATMENT WITH TELBIVUDINE by Poynard, T, Hou, J.-L, Chutaputti, A, Manns, M, Naoumov, N

Get full text

[58] SUSTAINED OFF-TREATMENT HBeAg RESPONSE IN TELBIVUDINE AND LAMIVUDINE TREATED HBeAg-POSITIVE PATIENTS FROM THE GLOBE STUDY by Poynard, T, Chutaputti, A, Hwang, S.G, Lim, S.G, Heathcote, T, Kuan, Y.Y, Lee, S, Naoumov, N, Zeuzem, S, Brown, N.A

Get full text

1012 TELBIVUDINE-INDUCED HBEAG SEROCONVERSION IN CHRONIC HEPATITIS B (CHB) IS DURABLE DURING 2 YEARS OFF-TREATMENT FOLLOW-UP by Liaw, Y.-F, Wursthorn, K, Thongsawat, S, Zhou, X.-Q, Hwang, S.G, Chutaputti, A, Teo, E.K, Gane, E.J, Jung, M, Wedemeyer, H, Avila, C

Get full text

Peginterferon α-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B by Cooksley, W. G. E., Piratvisuth, T., Lee, S.-D., Mahachai, V., Chao, Y.-C., Tanwandee, T., Chutaputti, A., Chang, W. Yu, Zahm, F. E., Pluck, N.

“…Current therapies for chronic hepatitis B (CHB) have a number of limitations, and better treatment options are needed. Peginterferon α‐2a (40 kDa) is superior…”
Get full text

Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B by Cooksley, W G E, Piratvisuth, T, Lee, S-D, Mahachai, V, Chao, Y-C, Tanwandee, T, Chutaputti, A, Chang, W Yu, Zahm, F E, Pluck, N

“…Current therapies for chronic hepatitis B (CHB) have a number of limitations, and better treatment options are needed. Peginterferon alpha-2a (40 kDa) is…”
Get full text

Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C by Sugauchi, Fuminaka, Orito, Etsuro, Ichida, Takafumi, Kato, Hideaki, Sakugawa, Hiroshi, Kakumu, Shinichi, Ishida, Takafumi, Chutaputti, Anuchit, Lai, Ching-Ling, Gish, Robert G., Ueda, Ryuzo, Miyakawa, Yuzo, Mizokami, Masashi

“…Background & Aims: Hepatitis B virus (HBV) isolates of genotype B (HBV/B) with or without the recombination with genotype C over the precore region plus core…”
Get full text

Hepatitis B Virus of Genotype B with or without Recombination with Genotype C over the Precore Region plus the Core Gene by Sugauchi, Fuminaka, Orito, Etsuro, Ichida, Takafumi, Kato, Hideaki, Sakugawa, Hiroshi, Kakumu, Shinichi, Ishida, Takafumi, Chutaputti, Anuchit, Lai, Ching-Ling, Ueda, Ryuzo, Miyakawa, Yuzo, Mizokami, Masashi

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Management of refractory ascites and hepatorenal syndrome by Chutaputti, Anuchit

“…Refractory ascites and hepatorenal syndrome (HRS) are the late complications of the terminal stages of cirrhosis. The definitions of refractory ascites and HRS…”
Get full text

Adverse effects and other safety aspects of the hepatitis C antivirals by Chutaputti, Anuchit

“…The preferred treatment for patients with chronic hepatitis C, either treatment-naive, relapsers or nonresponders to IFN monotherapy, is now IFN-ribavirin…”
Get full text

PG112 RESOURCE UTILIZATION AND DIRECT MEDICAL COST OF CHRONIC HEPATITIS C (CHC) IN THAILAND: A HEAVY BUT MANAGEABLE ECONOMIC BURDEN by Thongsawat, S, Piratvisuth, T, Pramoolsinsap, C, Chutaputti, A, Tanwandee, T, Sukarom, I, Tinmanee, S

Get full text

Hepatitis B virus genotypes and clinical manifestation among hepatitis B carriers in Thailand by SUGAUCHI, FUMINAKA, CHUTAPUTTI, ANUCHIT, ORITO, ETSURO, KATO, HIDEAKI, SUZUKI, SEIJI, UEDA, RYUZO, MIZOKAMI, MASASHI

“…Background: Hepatitis B virus (HBV) genotypes have distinct geographic distributions. The aim of the present study was to evaluate the distribution of HBV…”
Get full text

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update by Liaw, Yun-Fan, Leung, Nancy, Guan, Richard, Lau, George K.K., Merican, Ismail, McCaughan, Geoff, Gane, Edward, Kao, Jia-Horng, Omata, Masao

“…:
 Background/Aims: A large amount of new data on the treatment of chronic hepatitis B has become available such that the 2003 consensus statement requires…”
Get full text

Interspousal transmission of hepatitis C in Thailand by Boonyarad, Vorayod, Chutaputti, Anuchit, Choeichareon, Sommai, Bedi, Kavita, Theamboonlers, Apiradee, Chinchai, Teeraporn, Poovorawan, Yong

“…Previous studies evaluating the possibility of interspousal sexual transmission of hepatitis C virus (HCV) have yielded many conflicting results. Our study was…”
Get full text

Treatment with peginterferon alfa-2a (40KD) (PEGASYS®) results in improved rates of response compared to conventional interferon in patients with HBEAG positive chronic hepatitis B harboring HBV genotypes B or ‘difficult-to-treat’ genotype C by Cooksley, W.G.E., Lai, M.-Y., Piratvisuth, T., Wang, Y.-J., Mahachai, V., Chao, Y.-C., Tanwandee, T., Chutaputti, A., Chang, W.-Y., Zahm, F.E., Pluck, N.

Get full text